Etidronate Disodium (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Etidronate Disodium drug offered from Mylan Pharmaceuticals Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | etidronate disodium |
SUBSTANCE NAME: | ETIDRONATE DISODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-01-02 |
END MARKETING DATE: | 2019-11-30 |
Etidronate Disodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Etidronate Disodium from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2008-01-02 |
END MARKETING DATE: | 2019-11-30 |
PRODUCT ID: | 0378-3286_1c3be377-d59d-4424-b7bd-649e3133b8cd |
PRODUCT NDC: | 0378-3286 |
APPLICATION NUMBER: | ANDA075800 |
Other ETIDRONATE DISODIUM Pharmaceutical Manufacturers / Labelers: